The University of Chicago Header Logo

Connection

Philip Charles Hoffman to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Philip Charles Hoffman has written about Protein Kinase Inhibitors.
Philip Charles Hoffman
Connection Strength
0.137
Protein Kinase Inhibitors
  1. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
    View in: PubMed
    Score: 0.076
  2. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.